Protocol 3: metabolic health optimization Goal: Reduce liver fat, improve insulin sensitivity, address metabolic syndrome Tirzepatide approach: Standard escalation to 10 mg Produces moderate liver fat reduction Significant HbA1c improvements (if diabetic) Meaningful but not maximal metabolic improvements Retatrutide approach: Escalation to 8-12 mg 86% of patients achieved normal liver fat at 12 mg Superior metabolic marker improvements across all measures Glucagon component directly targets hepatic lipid metabolism If metabolic health is your primary goal rather than the number on the scale, the retatrutide dosage chart offers something tirzepatide fundamentally cannot: direct glucagon-mediated liver fat reduction
pernicious anemia
Consequently, it contributes to addressing various cosmetic skin concerns, such as wrinkles, fine lines, dry skin, saggy skin, and dark spots
In contrast, NO induces melanogenesis by increasing the amounts of tyrosinase and tyrosinase-related protein 1
And that really only got so famous when they took the chance to study that at an even higher dose in people who didnt have diabetes but had dysmetabolism and obesity
Br J Pharmacol 179(4):600624 Shah M, Vella A (2014) Effects of GLP-1 on appetite and weight